|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.998
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.994
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.992
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.989
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.988
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.981
|
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.979
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.974
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.974
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.971
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.969
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.967
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.964
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
2 |
0.963
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.962
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.961
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.945
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.941
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.939
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.937
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.930
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.930
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
1 |
0.928
|
|
|
|
viral genome replication
|
GO:0019079 |
17 |
0.919
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.915
|
|
|
|
production of small rna involved in gene silencing by rna
|
GO:0070918 |
6 |
0.901
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.900
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.897
|
|
|
|
regulation of myelination
|
GO:0031641 |
20 |
0.897
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
19 |
0.895
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.883
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.882
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.874
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.864
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.853
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.847
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.844
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.842
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.838
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.830
|
|
|
|
dsrna fragmentation
|
GO:0031050 |
6 |
0.829
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.820
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.817
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.813
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.796
|
|
|
|
cellular response to dsrna
|
GO:0071359 |
12 |
0.787
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.780
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.779
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.778
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.770
|
|
|
|
inner ear receptor cell development
|
GO:0060119 |
39 |
0.764
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.757
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.744
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.729
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.727
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.725
|
|
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.722
|
|
|
|
rna phosphodiester bond hydrolysis endonucleolytic
|
GO:0090502 |
10 |
0.721
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.721
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.712
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.700
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.695
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.693
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.687
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.687
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.682
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.668
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.663
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.661
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.656
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.652
|
|
|
|
mda 5 signaling pathway
|
GO:0039530 |
1 |
0.650
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.646
|
|
|
|
cardiac neural crest cell development involved in outflow tract morphogenesis
|
GO:0061309 |
6 |
0.646
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.645
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.641
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.640
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.636
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.632
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.630
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.619
|
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.613
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.611
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.604
|
|
|
|
cardiac neural crest cell differentiation involved in heart development
|
GO:0061307 |
8 |
0.598
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.593
|
|
|
|
production of mirnas involved in gene silencing by mirna
|
GO:0035196 |
6 |
0.581
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.579
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.578
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.576
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.572
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.572
|
|
|
|
enamel mineralization
|
GO:0070166 |
7 |
0.570
|
|
|
|
negative regulation of defense response to virus
|
GO:0050687 |
6 |
0.569
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.568
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.568
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.568
|
|
|
|
positive regulation of interferon beta production
|
GO:0032728 |
8 |
0.566
|
|
|
|
regulation of mirna metabolic process
|
GO:2000628 |
4 |
0.559
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.556
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.544
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.542
|
|
|
|
mirna metabolic process
|
GO:0010586 |
10 |
0.539
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.536
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.534
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.533
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.531
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.530
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.522
|
|
|
|
ganglion development
|
GO:0061548 |
13 |
0.522
|
|
|
|
regulation of odontogenesis of dentin containing tooth
|
GO:0042487 |
11 |
0.521
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.521
|
|
|
|
negative regulation of response to biotic stimulus
|
GO:0002832 |
10 |
0.506
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.505
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.504
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.503
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.498
|
|
|
|
positive regulation of mirna metabolic process
|
GO:2000630 |
1 |
0.498
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.497
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.491
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.490
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.482
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.479
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.475
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.474
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.471
|
|
|
|
regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039531 |
2 |
0.470
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.464
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.452
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.449
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.447
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.446
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.444
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.436
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.431
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.427
|
|
|
|
amelogenesis
|
GO:0097186 |
12 |
0.415
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.413
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.408
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.407
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.400
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.397
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.390
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.388
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.386
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.385
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
13 |
0.384
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.377
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.376
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.374
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.371
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.363
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.362
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.361
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.356
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.355
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.354
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.353
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.352
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.349
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.349
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.347
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.345
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.345
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.344
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.342
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.342
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.341
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.340
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.337
|
|
|
|
intestinal epithelial cell development
|
GO:0060576 |
12 |
0.337
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.332
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.332
|
|
|
|
rna stabilization
|
GO:0043489 |
9 |
0.332
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.325
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.324
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.322
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.317
|
|
|
|
mrna stabilization
|
GO:0048255 |
9 |
0.313
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.313
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.311
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.309
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.305
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.304
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
23 |
0.302
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.300
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.293
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.293
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.292
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.286
|
|
|
|
spindle assembly
|
GO:0051225 |
13 |
0.285
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.284
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.282
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.280
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.278
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.275
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.275
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.274
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.273
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.272
|
|
|
|
zygote asymmetric cell division
|
GO:0010070 |
2 |
0.271
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.270
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.269
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.267
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.263
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.262
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.257
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.256
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.252
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.252
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.250
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.249
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.248
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.248
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.248
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.245
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.243
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.240
|
|
|
|
intestinal epithelial cell differentiation
|
GO:0060575 |
14 |
0.239
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.237
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.236
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.234
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.234
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.232
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.231
|
|
|
|
negative regulation of rig i signaling pathway
|
GO:0039536 |
2 |
0.230
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.229
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.228
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.227
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.225
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.224
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.222
|
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
5 |
0.215
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.215
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.213
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.213
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.211
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.209
|
|
|
|
negative regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway
|
GO:0039532 |
2 |
0.207
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.206
|
|
|
|
cardiac neural crest cell development involved in heart development
|
GO:0061308 |
7 |
0.206
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.205
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.204
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.203
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.201
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.201
|
|
|
|
cellular response to virus
|
GO:0098586 |
7 |
0.198
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.198
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.197
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.197
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.196
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.195
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.193
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.191
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
22 |
0.191
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.186
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.185
|
|
|
|
negative regulation of schwann cell proliferation
|
GO:0010626 |
1 |
0.184
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.182
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.181
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.181
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.180
|
|
|
|
glial cell proliferation
|
GO:0014009 |
10 |
0.179
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.179
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.177
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.176
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.176
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.176
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.173
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.173
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.172
|
|
|
|
viral entry into host cell
|
GO:0046718 |
15 |
0.171
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
8 |
0.164
|
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.164
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.160
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.159
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.158
|
|
|
|
asymmetric cell division
|
GO:0008356 |
8 |
0.157
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.157
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.151
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.150
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.149
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.148
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.146
|
|
|
|
ncrna processing
|
GO:0034470 |
26 |
0.143
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.143
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.143
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.140
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.139
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.139
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.137
|
|
|
|
negative regulation of viral release from host cell
|
GO:1902187 |
6 |
0.135
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.135
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.135
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.135
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.130
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
6 |
0.129
|
|
|
|
meiotic spindle organization
|
GO:0000212 |
9 |
0.120
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.118
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.116
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.113
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.106
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.104
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.104
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.099
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.099
|
|
|
|
interferon alpha production
|
GO:0032607 |
7 |
0.098
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.095
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.094
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.094
|
|
|
|
movement in host environment
|
GO:0052126 |
15 |
0.092
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.092
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
5 |
0.089
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.089
|
|
|
|
nlrp3 inflammasome complex assembly
|
GO:0044546 |
5 |
0.088
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.084
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.083
|
|
|
|
regulation of rna stability
|
GO:0043487 |
26 |
0.081
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.079
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.076
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.076
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.074
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.072
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.072
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.071
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.071
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.070
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.069
|
|
|
|
entry into host cell
|
GO:0030260 |
15 |
0.069
|
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.068
|
|
|
|
positive regulation of response to biotic stimulus
|
GO:0002833 |
15 |
0.067
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.066
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.065
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.065
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.064
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.063
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.061
|
|
|
|
response to exogenous dsrna
|
GO:0043330 |
22 |
0.060
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.060
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.060
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.059
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.059
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.058
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.058
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.055
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.054
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.054
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.054
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.054
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.054
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.054
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.053
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.053
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.052
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.050
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.049
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.048
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.047
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.047
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.047
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.047
|
|
|
|
positive regulation of interleukin 18 production
|
GO:0032741 |
2 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.045
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.045
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.044
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.044
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.043
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.042
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.042
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.041
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.041
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.040
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.039
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.039
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.039
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.038
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.037
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.037
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.037
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.037
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.036
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.036
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.036
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.035
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.033
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.033
|
|
|
|
negative regulation of interleukin 6 production
|
GO:0032715 |
17 |
0.032
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.032
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.032
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.031
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.031
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.030
|
|
|
|
viral release from host cell
|
GO:0019076 |
6 |
0.030
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.030
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.029
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.029
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.029
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.028
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.028
|
|
|
|
response to type i interferon
|
GO:0034340 |
12 |
0.027
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.027
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.027
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.026
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.026
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.026
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.025
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.025
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.025
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.024
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.024
|
|
|
|
positive regulation of transcription factor import into nucleus
|
GO:0042993 |
8 |
0.024
|
|
|
|
transcription factor import into nucleus
|
GO:0042991 |
26 |
0.024
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.023
|
|
|
|
regulation of schwann cell differentiation
|
GO:0014038 |
1 |
0.023
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.023
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.023
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.023
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.023
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.022
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.022
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.022
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.022
|
|
|
|
production of sirna involved in rna interference
|
GO:0030422 |
1 |
0.022
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.022
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.022
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.020
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.020
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.019
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.019
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.019
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.019
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.019
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.019
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.019
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.019
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.019
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.018
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.018
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.018
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.018
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.018
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.018
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.017
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.017
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.017
|
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
12 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
7 |
0.017
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.017
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.017
|
|
|
|
regulation of myd88 dependent toll like receptor signaling pathway
|
GO:0034124 |
2 |
0.017
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
17 |
0.017
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.016
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.016
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.016
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.015
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.015
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.015
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
